PODDInsulet Corporation

CSNasdaq (XNAS)·USD

Identity

Security key: 20270
Ticker: PODD
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2007-05-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PODD

Detail

Enriched 2026-08-14 20:47

Market cap: $10,060,520,106.94
Shares outstanding (class): 69,354,199
Shares outstanding (weighted): 69,354,199
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 5,400
Location: ACTON, MA
Homepage: https://www.insulet.com
Description: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Market cap and share counts drift.

Funds holding this security

380 funds · 387 positions · $3.71B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$470.20M	0.02%	2,240,761 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$375.06M	0.03%	1,787,361 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$189.85M	0.03%	904,722 NS	FIGI
T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC.	—	$181.69M	0.81%	865,860 NS	FIGI
N/A —	—	$171.88M	0.03%	819,099 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$170.31M	0.10%	811,608 NS	FIGI
VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS	VO	$159.47M	0.08%	759,976 NS	FIGI
VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS	VUG	$126.56M	0.04%	603,117 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$107.43M	0.28%	511,958 NS	FIGI
iShares Russell Mid-Cap Growth ETF iShares Trust	IWP	$98.84M	0.53%	471,007 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$95.39M	0.25%	454,561 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$83.23M	0.03%	396,637 NS	FIGI
iShares U.S. Medical Devices ETF iShares Trust	IHI	$63.54M	2.00%	302,798 NS	FIGI
Nomura Mid Cap Growth Fund IVY FUNDS	—	$59.83M	2.00%	285,126 NS	FIGI
iShares Russell 1000 Growth ETF iShares Trust	IWF	$59.33M	0.05%	282,731 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPODD
FIGI_COMPOSITEBBG000R7XX87
FIGI_SHARE_CLASSBBG001SRF439
CIK0001145197
ISINUS45784P1012
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Medical Devices
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Insulet Corporation develops and sells insulin delivery systems, which are medical devices.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.